Sanofi-aventis Japan Acquires Production and Sales Rights of Ancaron Antiarrhythmic Agent from Taisho Pharmaceutical.
In the meantime, Taisho Pharmaceutical and its subsidiary Taisho Toyama Pharmaceutical will continue to manufacture and sell the agent by signing a consignment contract with Sanofi-aventis Japan.
Ancaron, which was first introduced to Japan in 1992, is currently marketed over 100 countries worldwide.
Source: JCN http://www.japancorp.net
Copyright [c] 2005 Japan Corporate News Network. All rights reserved.
|Printer friendly Cite/link Email Feedback|
|Publication:||JCNN News Summaries|
|Date:||Oct 15, 2005|
|Previous Article:||Alfresa Pharma to Become Distributor of Anafranil Antidepressant.|
|Next Article:||AnGes MG, Osaka University, Aoki Undertake Co-development of Fully Bioabsorbable Stent.|